Abstract
While recent studies have demonstrated that secondary CD8+ T cells develop into effector-memory cells, the impact of particular vaccine regimens on the elicitation of these cells remains poorly defined. In the present study we evaluated the effect of three different immunogens--recombinant vaccinia, recombinant adenovirus, and plasmid DNA--on the generation of memory cellular immune responses. We found that vectors that induce the rapid movement of CD8+ T cells into the memory compartment during a primary immune response also drive a rapid differentiation of these cells into effector-memory CD8+ T cells following a secondary immunization. In contrast, the functional profiles of both CD8+ and CD4+ T cells, assessed by measuring antigen-stimulated gamma interferon and interleukin-2 production, were not predominantly shaped by the boosting immunogen. We also demonstrated that the in vivo expression of antigen by recombinant vectors was brief following boosting immunization, suggesting that antigen persistence has a minimal impact on the differentiation of secondary CD8+ T cells. When used in heterologous or in homologous prime-boost combinations, these three vectors generated antigen-specific CD8+ T cells with different phenotypic profiles. Expression of the memory-associated molecule CD27 on effector CD8+ T cells decreased following heterologous but not homologous boosting, resulting in a phenotypic profile similar to that seen on primary CD8+ T cells. These data therefore suggest that the phenotype of secondary CD8+ T cells is determined predominantly by the boosting immunogen whereas the cytokine profile of these cells is shaped by both the priming and boosting immunogens.
MeSH Terms
Adenoviridae/genetics,immunology
Animals
CD4-Positive T-Lymphocytes/immunology
CD8-Positive T-Lymphocytes/immunology
Female
Immunization, Secondary
Immunologic Memory
Interferon-gamma/biosynthesis
Interleukin-2/biosynthesis
Mice
Mice, Inbred BALB C
Plasmids/genetics
T-Lymphocyte Subsets/immunology
Tumor Necrosis Factor Receptor Superfamily, Member 7/biosynthesis
Vaccines, DNA/immunology
Vaccines, Synthetic/immunology
Vaccinia virus/genetics,immunology
Chemicals
Interleukin-2
Tumor Necrosis Factor Receptor Superfamily, Member 7
Vaccines, DNA
Vaccines, Synthetic
Interferon-gamma
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hovav Avi-Hai
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02115, USA.
Panas Michael W
Osuna Christa E
Cayabyab Mark J
Autissier Patrick
Letvin Norman L
References (24)
24 references, click to expand
-
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.
Nature. 1999 Oct 14;401(6754):708-12
PMID: 10537110
-
Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
J Immunol. 2006 Nov 15;177(10):6626-33
PMID: 17082574
-
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
J Gen Virol. 2001 Sep;82(Pt 9):2215-23
PMID: 11514732
-
Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization.
J Immunol. 2001 Nov 1;167(9):5386-94
PMID: 11673557
-
Cross-presentation in viral immunity and self-tolerance.
Nat Rev Immunol. 2001 Nov;1(2):126-34
PMID: 11905820
-
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.
Nature. 2003 Feb 20;421(6925):852-6
PMID: 12594515
-
CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.
J Exp Med. 2003 Nov 3;198(9):1369-80
PMID: 14581610
-
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.
Nat Immunol. 2003 Dec;4(12):1191-8
PMID: 14625547
-
CD4 T cell-dependent CD8 T cell maturation.
J Immunol. 2004 Mar 1;172(5):2834-44
PMID: 14978084
-
Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5610-5
PMID: 15044705
-
Memory CD8 T-cell differentiation during viral infection.
J Virol. 2004 Jun;78(11):5535-45
PMID: 15140950
-
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.
Nat Immunol. 2004 Sep;5(9):927-33
PMID: 15300249
-
Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant.
Science. 1992 Jan 17;255(5042):333-6
PMID: 1372448
-
CD27: marker and mediator of T-cell activation?
Immunol Today. 1994 Jul;15(7):307-11
PMID: 8086099
-
Phenotypic and functional separation of memory and effector human CD8+ T cells.
J Exp Med. 1997 Nov 3;186(9):1407-18
PMID: 9348298
-
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.
Nature. 2005 Mar 3;434(7029):88-93
PMID: 15744305
-
Prime-boost immunisation strategies for tuberculosis.
Microbes Infect. 2005 May;7(5-6):962-7
PMID: 15890555
-
Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.
J Immunol. 2005 Oct 1;175(7):4686-96
PMID: 16177116
-
Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.
J Exp Med. 2006 Apr 17;203(4):919-32
PMID: 16567385
-
Advances in tuberculosis vaccine strategies.
Nat Rev Microbiol. 2006 Jun;4(6):469-76
PMID: 16710326
-
Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.
J Immunol. 2006 Jul 15;177(2):831-9
PMID: 16818737
-
Signals required for programming effector and memory development by CD8+ T cells.
Immunol Rev. 2006 Jun;211:81-92
PMID: 16824119
-
Inflaming the CD8+ T cell response.
Immunity. 2006 Jul;25(1):19-29
PMID: 16860754
-
CD27 is required for generation and long-term maintenance of T cell immunity.
Nat Immunol. 2000 Nov;1(5):433-40
PMID: 11062504